1. Home
  2. LGVN vs COCH Comparison

LGVN vs COCH Comparison

Compare LGVN & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGVN
  • COCH
  • Stock Information
  • Founded
  • LGVN 2014
  • COCH 1995
  • Country
  • LGVN United States
  • COCH United States
  • Employees
  • LGVN N/A
  • COCH N/A
  • Industry
  • LGVN Medicinal Chemicals and Botanical Products
  • COCH Blank Checks
  • Sector
  • LGVN Health Care
  • COCH Finance
  • Exchange
  • LGVN Nasdaq
  • COCH Nasdaq
  • Market Cap
  • LGVN 25.2M
  • COCH 29.8M
  • IPO Year
  • LGVN 2021
  • COCH N/A
  • Fundamental
  • Price
  • LGVN $1.56
  • COCH $1.48
  • Analyst Decision
  • LGVN Strong Buy
  • COCH Strong Buy
  • Analyst Count
  • LGVN 3
  • COCH 3
  • Target Price
  • LGVN $8.67
  • COCH $8.00
  • AVG Volume (30 Days)
  • LGVN 161.2K
  • COCH 26.3K
  • Earning Date
  • LGVN 02-28-2025
  • COCH 04-01-2025
  • Dividend Yield
  • LGVN N/A
  • COCH N/A
  • EPS Growth
  • LGVN N/A
  • COCH N/A
  • EPS
  • LGVN N/A
  • COCH N/A
  • Revenue
  • LGVN $1,852,000.00
  • COCH $278,000.00
  • Revenue This Year
  • LGVN $208.32
  • COCH N/A
  • Revenue Next Year
  • LGVN $43.96
  • COCH $19.76
  • P/E Ratio
  • LGVN N/A
  • COCH N/A
  • Revenue Growth
  • LGVN 141.46
  • COCH 15.35
  • 52 Week Low
  • LGVN $0.77
  • COCH $1.17
  • 52 Week High
  • LGVN $6.40
  • COCH $11.46
  • Technical
  • Relative Strength Index (RSI)
  • LGVN 45.58
  • COCH 45.07
  • Support Level
  • LGVN $1.53
  • COCH $1.39
  • Resistance Level
  • LGVN $1.71
  • COCH $1.62
  • Average True Range (ATR)
  • LGVN 0.13
  • COCH 0.13
  • MACD
  • LGVN 0.02
  • COCH 0.00
  • Stochastic Oscillator
  • LGVN 38.30
  • COCH 31.03

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

About COCH Envoy Medical Inc.

Envoy Medical Inc is a hearing health company focused on providing innovative medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life.

Share on Social Networks: